Tabula Rasa HealthCare (TRHC) Misses Q4 EPS by 1c, Offers Guidance

Tabula Rasa HealthCare (NASDAQ: TRHC) reported Q4 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $85.7 million versus the consensus estimate of $85.19 million.

GUIDANCE:

Tabula Rasa HealthCare sees Q1 2022 revenue of $84-86 million, versus the consensus of $85.6 million.

Tabula Rasa HealthCare sees FY2022 revenue of $371-377 million, versus the consensus of $367.9 million.

For earnings history and earnings-related data on Tabula Rasa HealthCare (TRHC) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Stantec (STN) Tops Q2 EPS by 47c
• Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c